Dr. Chad B. Gunnlaugsson, MD

Dr. Gunnlaugsson practices at Southeastern Ear Nose Throat Allergy and Sleep Disorders Institute in Columbia, South Carolina.

Dr. Gunnlaugsson's NPI, 1194755314, was assigned on July 4, 2006. Dr. Gunnlaugsson graduated from University of North Carolina School of Medicine in 1998. Dr. Gunnlaugsson holds South Carolina license 28760.

Dr. Gunnlaugsson's primary practice is Southeastern Ear Nose Throat Allergy and Sleep Disorders Institute, at 114 Gateway Corporate Blvd, Columbia, SC 29203 in Richland County. The practice phone is (803) 509-7200.

Dr. Gunnlaugsson's primary practice is Southeastern Ear Nose Throat Allergy and Sleep Disorders Institute in Columbia, South Carolina. Dr. Gunnlaugsson is also affiliated with MUSC Health Columbia Medical Center Downtown. The medical group on file is Southeastern Ear, Nose & Throat, Allergy & Sleep. Dmand AI also links Dr. Gunnlaugsson to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gunnlaugsson practices, 2 sites in all. Vendor and product names are available with a free account.

Otolaryngology is Dr. Gunnlaugsson's primary specialty in the NPI Registry, under taxonomy code 207Y00000X. Dr. Gunnlaugsson is board certified in otolaryngology by the American Board of Otolaryngology - Head and Neck Surgery. Dmand AI has Dr. Gunnlaugsson's licenses on file in 3 states: South Carolina, Florida and Michigan.

Dmand AI lists chronic nasal allergies, chronic sinusitis, ear eustachian tube disorders, ear infection, endoscopic sinus surgery, hearing loss and impairment, larynx and vocal cord disease and swimmer's ear among the conditions Dr. Gunnlaugsson treats.

CMS data shows 25,143 Medicare services from Dr. Gunnlaugsson across 10 procedure codes in 2024, for 656 Medicare patients. Medicare paid $321,940 for them. Every service was in an office.

CMS counts 656 Medicare patients who saw Dr. Gunnlaugsson in 2024. The largest group is 65 to 74, with 358 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 2% are also on Medicaid. Their average risk score is 0.86, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gunnlaugsson's median patient age at 58, with 59% women.

In 2024, Dr. Gunnlaugsson wrote 373 Medicare Part D claims for 144 patients. 91% of them were for generic drugs. CMS names the drug for 269 of them, across 10 drugs with 11 or more claims each, at $8,832 in total drug cost. In 2023, CMS named 289 claims across 10 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gunnlaugsson for performance year 2024, reported as part of a group. Dr. Gunnlaugsson accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Gunnlaugsson. Dr. Gunnlaugsson's most frequent co-authors are Douglas B. Chepeha, MD, Mark David Iannettoni, MD and Robert Weatherly, MD.

CMS Open Payments shows 20 general payments to Dr. Gunnlaugsson from 16 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 78% of the total. Intersect ENT, Inc. paid the most, $100.

Dmand AI lists 3 awards for Dr. Gunnlaugsson, most recently Regional Top Doctor in 2014.

Dr. Gunnlaugsson graduated from University of North Carolina School of Medicine in 1998. Dr. Gunnlaugsson is a member of NHS and AASM.

Dr. Gunnlaugsson is in network with 16 carriers, including Aetna, Elevance and HCSC. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.